This inventor holds 2 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignee: Agensys, Inc.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Innovations of Brian Alan Mendelsohn
Introduction
Brian Alan Mendelsohn is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of peptide analogs for cancer treatment. With a total of 2 patents, Mendelsohn's work is recognized for its potential impact on medical therapies.
Latest Patents
Mendelsohn's latest patents include "Derivatives of dolaproine-dolaisoleuine peptides" and "Derivatives of dolaproine-dolaisoleucine peptides." Both patents provide peptide analogs, pharmaceutical compositions comprising such compounds, and methods of treating cancer with these innovative compounds. His research focuses on creating effective treatments that could improve patient outcomes in oncology.
Career Highlights
Throughout his career, Mendelsohn has been associated with Agensys, Inc., where he has contributed to groundbreaking research in peptide-based therapies. His work has garnered attention in the scientific community, showcasing his dedication to advancing medical science.
Collaborations
Mendelsohn has collaborated with esteemed colleagues such as Stuart Daniel Barnscher and Julien Dugal-Tessier. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to significant advancements in their field.
Conclusion
Brian Alan Mendelsohn's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a key inventor in cancer treatment research. His work continues to inspire advancements in medical therapies that could benefit many patients in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
